eniluracil/5-FU combination tablet
Term · Oncology and biomedicine · MLC-T-ONC-013354
A combination tablet of ethynyluracil and fluorouracil. Fluorouracil is an antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Ethynyluracil is an orally-active fluoropyrimidine analog that inhibits dihydropyrimidine dehydrogenase, the rate-limiting enzyme that catabolizes and inactivates 5-fluorouracil in the liver. This may lead to an increase in the bioavailability and, effectiveness of fluorouracil.
| Identifier | MLC-T-ONC-013354 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 776C85/5-FU; ethynyluracil/fluorouracil; GW776/5-fluorouracil; GW776/5-FU |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013354",
"term": "eniluracil/5-FU combination tablet",
"field": "Oncology and biomedicine",
"definition": "A combination tablet of ethynyluracil and fluorouracil. Fluorouracil is an antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Ethynyluracil is an orally-active fluoropyrimidine analog that inhibits dihydropyrimidine dehydrogenase, the rate-limiting enzyme that catabolizes and inactivates 5-fluorouracil in the liver. This may lead to an increase in the bioavailability and, effectiveness of fluorouracil.",
"synonyms": [
"776C85/5-FU",
"ethynyluracil/fluorouracil",
"GW776/5-fluorouracil",
"GW776/5-FU"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/eniluracil-5-fu-combination-tablet/"
}
Record 6,694 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.